BioSolutions announced an expanded collaboration to develop, manufacture and co-commercialize animal-free proteins and enzymes across food & nutrition and bio-industrial markets.
This expansion broadens the scope of products, platforms and commercial opportunities that the companies will bring to market together. The partnership improves development and delivery timelines of the shared product roadmap, enabling both companies to bring fermentation-derived biomolecules to market at scale.
This synergistic partnership is slated to accelerate product development, reduce commercialization timelines and increase reach in high-growth markets across the globe. The expanded product portfolio is expected to include recombinant proteins and enzymes for food and nutrition and bio-industrial applications, where demand for animal origin-free ingredients and alternatives to petrochemical-derived ingredients continues to rise.
Key elements include a jointly managed product pipeline, mutual supply of strains and finished products across expression systems and aligned commercialization to move animal origin-free proteins and enzymes to market faster—supporting faster scale-up, clearer customer pathways, and stronger global delivery readiness.
